Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.

Reshaping Dosage Forms

This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.

Development of Taste-Masked Oral Dispersible Tablets of Cefpodoxime Proxetil

Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.

Frontrunners in Bispecific Antibodies

Topic

Articles

Roche has acquired a program to develop regenerative therapies for multiple sclerosis.

Roche Acquires Regenerative Medicines Program

Under this global collaboration, the companies will develop encapsulated cell therapies for treating Type 1 diabetes.

Lilly, Sigilon Partner on Encapsulated Cell Therapies for Diabetes

Celltrion received complete response letters from FDA for its rituximab and trastuzumab biosimilars.

FDA Issues CRLs to Celltrion for Two Biosimilars

Anthony Qu, PhD, vice president of Scientific Affairs at Halo Pharma, will give a presentation on fixed-dose combination products, drug products containing multiple active ingredients, as an effective approach for simplified dosing at CPhI North America on Wednesday, April 25, 2018 in Philadelphia, PA.

Halo Pharma Shows Fixed-Dose Combination Products are Effective for Simplified Dosing

Boehringer Ingelheim and OSE Immunotherapeutics have entered a global immuno-oncology partnership to develop a checkpoint inhibitor for treating advanced solid tumors.

Boehringer Ingelheim and OSE in Immuno-Oncology Deal Worth $1.7 Billion

Colorcon Inc. and Applied DNA signed a supply agreement granting Colorcon exclusive right to use Applied DNA’s SigNature molecular tags in film coatings for solid oral dosage forms, and non-exclusive rights to use it in inks and colorants for SOD pharmaceuticals.

Colorcon and Applied DNA to Join Forces in Taggants for Pharmaceutical Traceability

The companies have created Syna Therapeutics, a joint venture that will develop biosimilars and new molecules.

Reig Jofre and Leanbio Form Joint Venture to Develop Biosimilars

The European approval marks the first approval for a biosimilar in that region resulting from the companies’ joint portfolio.

Mylan and Biocon Get Approvals for Biosimilar Insulin Glargine in Europe and Australia

Fujifilm acquires cell culture media companies Irvine Scientific Sales Company and IS Japan.

Fujifilm Expands Bioprocessing Scope

The active pharmaceutical ingredient and excipient provider has expanded its parenteral ingredient manufacturing capacity and lab services.